Drug Approval News

The US Food and Drug Administration (FDA) has approved Rasonque (daraxonrasib), a new drug for advanced pancreatic cancer. This approval marks a significant dev

The US FDA has approved a new drug for pancreatic cancer that shows potential to extend patient survival.

Campaigners for Friedreich's Ataxia patients have made a final appeal to the HSE to approve the Skyclarys treatment before a decision is made next week.

Drug authorities have approved a new treatment for diabetics that allows for a once-weekly insulin injection instead of daily doses.

The U.S. FDA has classified Aurobindo's North Carolina plant as Voluntary Action Indicated (VAI), allowing pending applications for inhalers and other dosage fo

India's pharmaceutical industry has achieved a historic milestone with a new drug approval, showcasing its transformation from an importer to a global leader in

The Union Ministry of Health & Family Welfare has amended the Drugs Rules, 1945, to bar drugmakers from selling mislabelled or fraudulently approved products, e

An FDA panel has narrowly supported unapproved peptide drugs, despite FDA scientists finding little data on their effectiveness for conditions like ulcerative c

Pfizer's combination drug for prostate cancer has received priority review status from the U.S. FDA, with a target decision date set for the last quarter of 202